36C25018Q9305-000.docx

DOCX document 13 KB Posted

Attached to
Therasphere Therapy Federal contract opportunity
Solicitation number
36C25018Q9305
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10

About this file

36C25018Q9305 36C25018Q9305.docx

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FedBizOpps Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field FedBizOpps Special Notice Rev. March 2010 Therasphere Therapy 45409-1337 36C25018Q9305 N 325412 Department of Veterans Affairs Network Contracting Office 10 3140 Governor’s Place Blvd. Suite 210 Kettering OH 45409-1337 Angie Carpenter angie.carpenter@va.gov www.va.gov VA Homepage angie.carpenter@va.gov Contract Specialist

NOTICE OF INTENT TO SOLE SOURCE – THERASPHERE, Y-90 GLASS MICROSPHERE

The Department of Veterans Affairs, Louis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1) “soliciting from one source when CO determines that the circumstances of the contract action deem only one source reasonably available.” The VA intends to solicit and negotiate with Biocompatibles, Inc., 115 Hurley Road, Building 3, Oxford, CT 06478, for Therasphere, Y-90 Glass Microsphere Therapeutic doses. Therasphere is a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. It consists of microscopic glass spheres that are attached to a radioactive isotope (y-90) and then injected into the patient. The spheres are trapped in the liver where they can treat liver cancer. The Government believes that only one business can reasonably satisfy the agency requirements and intends to negotiate with only one source.

Other Contractors may identify their interest and capability by responding to this requirement by Friday, June 29, 2018, by 2:00PM EST. Such capabilities information will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. All information shall be furnished at no cost or obligation to the Government. A determination by the Government not to open the requirement to competition based upon responses to this notice is solely within the discretion of the Government. No solicitation is available now. All inquiries must be submitted by email to Angie Carpenter at angie.carpenter@va.gov with the subject: “RFQ 36C25018Q9305 Therasphere, Y-90 Glass Microsphere.”

File details come from the government source that posted it.